ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Combination therapy suppresses HIV-like virus in primates
March 08, 2018Broadly neutralising antibody treatment may target viral reservoir in monkeys… -
FDA grants breast cancer approval to Roche's Perjeta/Herceptin combo therapy
December 22, 2017Roche has announced that the FDA has granted approval to Perjeta in combination with Herceptin and a Perjeta-based) chemotherapy regimen for the adjuvant treatment of HER2-positive early breast cancer which is at a high chance of recurrence. -
Combined therapies increase side effects for patients with advanced breast cancer
November 06, 2017Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects… -
Merck Announces New Phase 2 Data on Investigational Triple Combination Therapy MK-3682B for Chronic
April 24, 2017indings Presented at The International Liver Congress™ 2017 Show High Rates of Sustained Virologic Response (SVR12) in Genotype 1 Patients for Whom Direct-Acting Antiviral Therapy Had Previously Failed -
Launch of Utibron Neohaler in the US
April 05, 2017Represents the latest combination therapy now available for the millions of patients living with COPD in the US.
Pharma Sources Insight January 2025
